Nature’s Miracle Allocates $20M to XRP for Cross-Border Transactions Wellgistics Health Plans XRP Integration for Real-Time Payments Chris Larsen Sells $200M in XRP Amid Market Volatility

XRP's latest price was $3.13, up 0.24% in the last 24 hours. Nature’s Miracle Holding Inc., a vertical farming technology company, has announced plans to allocate up to $20 million of its treasury to XRP. This move positions Nature’s Miracle as one of the first publicly traded U.S. entities to integrate XRP on such a significant scale. The decision is driven by XRP’s cost-efficiency and speed in cross-border transactions, aligning with the GENIUS Act, which encourages the use of cryptocurrencies for treasury management among corporates. CEO James Li highlighted the potential for improved speed and lower costs in cross-border transactions with XRP, which could influence other companies considering similar moves within regulated frameworks. The company intends to use staking mechanisms to generate yield from its XRP holdings, potentially enhancing its financial footing in the competitive agritech sector. This strategic approach could lead to increased liquidity and reduced market float for XRP, bolstering its role in corporate treasury strategies and propelling broader acceptance of the cryptocurrency.

Wellgistics Health, a Nasdaq-listed health-tech company, has filed an S-1 registration statement with the Securities and Exchange Commission detailing a plan to integrate XRP and the XRP Ledger (XRPL) across its payments and treasury operations. The company aims to use XRPL to process real-time, low-cost business-to-business payments among pharmacies, manufacturers, and vendors, and to expand its XRP holdings. The filing states that Wellgistics may raise capital through equity and debt offerings to purchase additional XRP, deploy those holdings to generate income, and use the asset as collateral for future financing. The disclosure follows a $50 million equity financing commitment from LDA Capital, which the company said will fund XRPL infrastructure and related initiatives. The S-1 positions XRP as an active balance sheet instrument, with the company intending to accumulate XRP and apply it to several functions, including as a payments rail, as collateral to secure financing, and as a source of income generation. The company indicated that treating XRP as collateral could provide liquidity without disrupting operations. It also outlined plans to raise capital specifically for digital asset acquisition, signaling that future issuances of equity or debt may be tied to enlarging its XRP position. Wellgistics will implement XRPL to support near-instant settlement and reduced fees for business partners, identifying a network of approximately 6,000 pharmacies and 150 manufacturers that will interface with the XRPL-based system. The stated objective is to streamline value transfer and improve liquidity across that ecosystem by avoiding the delays and costs present in traditional payment systems. The company also disclosed plans to seek income from its XRP holdings, framing this as an initiative to increase balance sheet efficiency and deploy XRP within core payment flows. Additionally, the S-1 includes risk disclosures tied to XRP’s regulatory status and ongoing litigation, warning that adverse legal or regulatory outcomes could affect XRP’s price and, as a result, the value of the company’s treasury assets and collateral. The filing also acknowledges public concerns about XRP’s utility, presenting its operational use of XRPL as a direct, measurable application within its logistics model.

Chris Larsen, a prominent figure in the crypto industry and co-founder of Ripple, has been actively selling XRP tokens following the cryptocurrency’s notable price surge. His recent divestment of approximately $200 million worth of XRP has drawn significant attention from market analysts and investors alike. While Larsen still holds a substantial 2.58 billion XRP, his sales activity is viewed by some as a potential catalyst for price volatility. The timing of these sales, particularly after XRP’s peak, suggests a strategic approach to capitalizing on market highs. However, the subsequent price correction has intensified speculation about the influence of large holders on XRP’s short-term performance. Market observers have noted that significant token sales by influential figures like Larsen can contribute to downward price pressure, especially during periods of market correction. CryptoQuant analyst J.A. Maartun posits that Larsen’s recent sale might merely be an initial move, implying that further sales could follow. This perspective underscores concerns about liquidity and supply dynamics within the XRP ecosystem. Conversely, some community members, including legal expert Bill Morgan, argue that attributing XRP’s price decline solely to Larsen’s sales oversimplifies broader market factors. These include macroeconomic conditions, regulatory developments, and overall investor sentiment, which collectively shape price trajectories. Chris Larsen’s sales activity invites comparison with fellow Ripple co-founder Jed McCaleb, who ceased selling XRP in July 2022 after a prolonged period of divestment. Both founders were originally allocated 9 billion XRP tokens each from Ripple’s 20 billion founder allocation in 2012. Larsen’s total sales since November amount to 107 million XRP, valued at approximately $3.3 billion at current prices. This strategic liquidation contrasts with McCaleb’s exit from selling, highlighting differing approaches to managing founder token holdings. Additionally, the enigmatic third co-founder, who remains anonymous, has not been involved in any public sales, adding another layer of complexity to the market dynamics surrounding XRP.

Recent developments surrounding XRP have been dominated by activity from Ripple co-founder Chris Larsen. Between July 17 and July 25, 2025, Larsen transferred approximately $140 million worth of XRP tokens to exchanges. This movement followed a similar $140 million transfer conducted in June 2025 and a $175 million transfer starting July 17th. These transfers have coincided with periods of heightened market volatility for the cryptocurrency. Analysts are scrutinizing the potential impact of Larsen's actions. CryptoQuant analyst J.A. Maartun indicated that the continued sales could signal further selling pressure, suggesting they might form part of a larger divestment strategy. Despite these transfers, Larsen retains a significant holding of 2.58 billion XRP tokens. His selling activity contrasts with fellow Ripple co-founder Jed McCaleb, who ceased his sales in July 2022 after divesting the majority of his initial allocation. Both founders received 9 billion XRP from Ripple's 2012 founder distribution. The market's reaction to these large-scale movements has prompted discussion among experts. Some observers and traders have linked notable declines in market sentiment and volatility directly to the timing of these transfers. However, legal expert Bill Morgan cautioned against attributing XRP's market behavior solely to founder sales, emphasizing the complexity of factors involved. Morgan highlighted the significant influence of regulatory updates, technological developments within the Ripple ecosystem, and overarching trends across the broader cryptocurrency market. Looking ahead, the actions of major token holders like Larsen remain a focal point for participants in the XRP market. The intricate relationship between substantial founder token transfers, market liquidity events, and external economic conditions underscores the challenge in forecasting short-term market movements. Analysts suggest that understanding the evolving landscape requires a balanced assessment, integrating insights from large holder behavior with the continual progress of industry-wide developments.